Inspira™ announces business plan targets

Company to aggressively promote inspira™ art100 in the u.s. and additional markets following fda clearance, as well as accelerate plans for ground-breaking inspira™ art (gen2) ra'anana, israel , june 20, 2024 /prnewswire/ -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn), (nasdaq: iinnw) (the "company" or "inspira"), a breakthrough medical technology company, announced today that the company's president and co-founder, mr.
IINN Ratings Summary
IINN Quant Ranking